Implications of an antiparallel dimeric structure of nonphosphorylated STAT1 for the activation-inactivation cycle.
about
Tyrosine phosphorylation regulates the partitioning of STAT1 between different dimer conformationsInborn errors of human STAT1: allelic heterogeneity governs the diversity of immunological and infectious phenotypesProtein tyrosine phosphatases as wardens of STAT signalingInhibition of STAT5: a therapeutic option in BCR-ABL1-driven leukemiaDimeric Quaternary Structure of the Prototypical Dual Specificity Phosphatase VH1BCR-ABL affects STAT5A and STAT5B differentiallyStructure of the unphosphorylated STAT5a dimer.Novel STAT1 alleles in otherwise healthy patients with mycobacterial disease.SH2 modified STAT1 induces HLA-I expression and improves IFN-γ signaling in IFN-α resistant HCV replicon cells.Characterization of a dominant-active STAT that promotes tumorigenesis in Drosophila.The different functions of Stat5 and chromatin alteration through Stat5 proteinsAlternative ways of modulating JAK-STAT pathway: Looking beyond phosphorylation.Two glutamic acid residues in the DNA-binding domain are engaged in the release of STAT1 dimers from DNA.Composition and assembly of STAT-targeting ubiquitin ligase complexes: paramyxovirus V protein carboxyl terminus is an oligomerization domain.A novel form of human STAT1 deficiency impairing early but not late responses to interferons.Clinically relevant dimer interface mutants of STAT1 transcription factor exhibit differential gene expression.A partial form of recessive STAT1 deficiency in humans.New activation modus of STAT3: a tyrosine-less region of the interleukin-22 receptor recruits STAT3 by interacting with its coiled-coil domainGain-of-function human STAT1 mutations impair IL-17 immunity and underlie chronic mucocutaneous candidiasis.A conserved motif in the linker domain of STAT1 transcription factor is required for both recognition and release from high-affinity DNA-binding sitesIdentification of Mouse Cytomegalovirus Resistance Loci by ENU Mutagenesis.The two faces of interferon-γ in cancer.DNA binding reduces the dissociation rate of STAT1 dimers and impairs the interdimeric exchange of protomers.Structural Basis of the Inhibition of STAT1 Activity by Sendai Virus C Protein.Identification of STAT2 serine 287 as a novel regulatory phosphorylation site in type I interferon-induced cellular responsesTracking STAT nuclear traffic.Recruitment of Stat1 to chromatin is required for interferon-induced serine phosphorylation of Stat1 transactivation domainWedelolactone, a naturally occurring coumestan, enhances interferon-γ signaling through inhibiting STAT1 protein dephosphorylation.STAT3 inhibition in prostate and pancreatic cancer lines by STAT3 binding sequence oligonucleotides: differential activity between 5' and 3' ends.The tumor suppressor function of STAT1 in breast cancerSignal transducer and activator of transcription 1 (STAT1) gain-of-function mutations and disseminated coccidioidomycosis and histoplasmosis.Preconditioning mediated by sublethal oxygen-glucose deprivation-induced cyclooxygenase-2 expression via the signal transducers and activators of transcription 3 phosphorylation.New and recurrent gain-of-function STAT1 mutations in patients with chronic mucocutaneous candidiasis from Eastern and Central Europe.Biology and significance of the JAK/STAT signalling pathways.Deciphering the modulation of gene expression by type I and II interferons combining 4sU-tagging, translational arrest and in silico promoter analysis.Paradigm shifts in the cell biology of STAT signalingInteferons pen the JAK-STAT pathway.Phosphorylation of IRF8 in a pre-associated complex with Spi-1/PU.1 and non-phosphorylated Stat1 is critical for LPS induction of the IL1B geneSTAT3 in CD4+ T helper cell differentiation and inflammatory diseases.Cross-regulation of signaling pathways by interferon-gamma: implications for immune responses and autoimmune diseases.
P2860
Q24644632-35D6BC9D-5689-433B-9846-F11DAEACB555Q26825342-0E2518E3-5144-4DA9-B2E8-1F852F1D7381Q26861574-E1B139C6-F556-45F4-9F00-D2C5E9E2BFFFQ27004027-C0372562-8C2B-4B51-B497-57135DAF7D06Q27653744-3E426755-E19B-4944-AD00-C30B4BB959E2Q28538914-8B9BD749-17F6-4B14-A272-8F7401A4B0FEQ30160122-D287E591-E1B6-4DC2-9A32-77CFDBA4F1AEQ33255341-A9DD9544-75A0-493B-B84C-38C2C4EE937FQ33719537-69979DFC-2574-40A6-AF7D-A59B54A0B507Q34037299-A42D8FF5-31B3-409E-97C6-A75452914398Q34293279-264B16EB-D19D-49DF-AB1C-063A92A26909Q34372827-8514AF90-1F25-403D-BE12-9A23AAA90FD0Q34392880-7EE9FE34-B133-44C2-876D-B07B8148BB9AQ34438089-E45616C1-77A0-4B3E-92D2-7E6B83FFBFCBQ34541567-286B1652-C49C-4BAE-A672-41B41BECBE9CQ34904659-9EBDB8DC-A9C0-4513-8C01-F19678A17AD6Q34980624-CCEBA9CB-3799-409F-B728-57FAF38DF770Q34994147-5507287A-B9BF-41DD-A556-358D55DA2477Q35144610-B4D55AAA-52F9-45AE-B1B8-3E4B71BB6680Q35171878-B886ED6A-6399-4FC4-8B9B-934E9E9691E9Q35259980-B3114702-7DEE-4667-BF68-7D30F3C0C60AQ35269015-45970714-BC18-4A9B-B6AA-C54784446932Q35531065-13E97724-959A-4950-80B2-3DE26BC95F7AQ36281889-C7E08DE8-F9B0-4666-AB11-C6680A5B8692Q36508798-F2AC2070-19DD-4E0C-8C5E-A43FA2778ECDQ36547212-2AF01FF0-D714-4109-9066-40A069BB26D7Q36732554-A402A65C-7DCE-49A9-81F6-4ABCF84D5931Q36850338-8B241609-B29D-44A6-8283-305AB4311827Q36922793-58E30DEC-6D2C-4ABD-8D76-FEDB6657B1DFQ37008995-2952EE0C-1EAF-4655-B0AF-D5753274C17BQ37101568-D56E5CF6-26C2-4162-8F16-D25E8A38C62AQ37104674-A90D1FAC-D059-4EC3-A5E2-733731CD0918Q37130222-E71C29E5-FF67-4F00-8912-A16992A14977Q37146441-EC331B26-11C3-4C32-A40C-2B6A34E634FFQ37197803-3ABCAD7D-74B4-4C70-8627-A17F9461F0D7Q37240242-19912594-1D6C-4963-B102-654D4281A6D1Q37259013-9D21B737-5FC4-41E2-B543-0004FD9DF564Q37284465-6E619C6B-F320-4D31-89ED-ED595E80783AQ37323270-28CF420B-6155-40B1-BB4B-FED97C0A0218Q37414046-F48901BD-55DF-4F41-81EC-11A88BB0106B
P2860
Implications of an antiparallel dimeric structure of nonphosphorylated STAT1 for the activation-inactivation cycle.
description
2005 nî lūn-bûn
@nan
2005 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի մարտին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Implications of an antiparalle ...... activation-inactivation cycle.
@ast
Implications of an antiparalle ...... activation-inactivation cycle.
@en
type
label
Implications of an antiparalle ...... activation-inactivation cycle.
@ast
Implications of an antiparalle ...... activation-inactivation cycle.
@en
prefLabel
Implications of an antiparalle ...... activation-inactivation cycle.
@ast
Implications of an antiparalle ...... activation-inactivation cycle.
@en
P2093
P2860
P356
P1476
Implications of an antiparalle ...... activation-inactivation cycle.
@en
P2093
James E Darnell
Johanna ten Hoeve
Kenji Takeuchi
Melissa A Henriksen
Minghao Zhong
Olaf Schaefer
Xiaomin Chen
P2860
P304
P356
10.1073/PNAS.0501063102
P407
P577
2005-03-07T00:00:00Z